Cytokine targeting in tumors using a bispecific antibody directed against carcinoembryonic antigen and tumor necrosis factor α

Cancer Research

Volumn 56, Issue 20, 1996, Pages 4758-4765

  Robert, Bruno ^a   Mach, Jean Pierre ^b   Mani, Jean Claude ^c   Ychou, Marc ^a   Folli, Silvio ^b   Artus, Jean Claude ^a,d   Pèlegrin, André ^a,d  

^a CENTRE VAL D AURELLE   (France)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c CNRS   (France)

^d Faculty of Medicine   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANTIGEN ANTIBODY REACTION; ARTICLE; CANCER IMMUNOTHERAPY; CANCER THERAPY; COLON CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TARGET CELL DESTRUCTION;

ANIMALS; ANTIBODIES, BISPECIFIC; ANTIBODY SPECIFICITY; CARCINOEMBRYONIC ANTIGEN; COLONIC NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; HUMANS; IMMUNOTOXINS; MICE; MICE, NUDE; TRANSPLANTATION, HETEROLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029821117     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Köhler, G., and Milstein. C Continuous cultures of fused cells secreting antibody of predefined specificity Nature (Lond.), 256: 495-497, 1975.
2. Buchegger, F., Pèlegrin, A., Delaloye, B., Bischof-Delaloye, A., and Mach, J-P. 131-I labeled F(ab′)2 fragments are more efficient and less toxic than intact anti-CEA antibodies in radioimmunotherapy of large human colon carcinoma grafted in nude mice. J. Nucl. Med , 31 1035-1044, 1990.
3. Corvalan, J. R. F., and Smith, W. Construction and characterisation of a hybrid-hybrid monoclonal antibody recognising both carcinoembryonic antigen (CEA) and vinca alkaloids Cancer Immunol. Immunother., 24: 127-132, 1987
4. French, R R , Penney, C A., Browning, A. C., Stirpe, F , George, A. J , and Glennie, M. J. Delivery of the ribosome-inactivating protein, gelonin, to lymphoma cells via CD22 and CD38 using bispecific antibodies Br J. Cancer, 71: 986-994, 1995.
5. Pimm, M. V , Robins, R A., Embleton, M J., Jacobs, E., Markham, A. J., Charleston, A , and Baldwin, R. W. A bispecific monoclonal antibody against methotrexate and a human tumour associated antigen augments cytotoxicity of methotrexate-carrier conjugate Br. J. Cancer, 61: 508-513, 1990.
6. Le Doussal, J M., Gautherot, E , Martin, M , Barbet, J., and Delaage, M Enhanced in vivo targeting of an asymmetric bivalent hapten to double-antigen-positive mouse B cells with monoclonal antibody conjugate cocktails J Immunol., 146: 169-175, 1991
7. Carswell, E A , Old, L J., Kassel, R. L., Green, S , Fiore, N , and Williamson, B An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl. Acad Sci. USA, 72: 3666-3670, 1975.
8. Balkwill, F. R , Lee, A., Aldam, G., Moodie, E., Thomas, J. A., Tavernier, J., and Fiers, W Human tumor xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferons. Cancer Res., 46: 3990-3993, 1986.
9. Asher, A. L., Mule, J. J , Reichert, C. M , Shiloni, E., and Rosenberg, S A. Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo. J. Immunol., 138: 963-974, 1987.
10. Rosenberg, S. A , Schwarz, S. L., and Spiess, P J. Combination immunotherapy for cancer, synergistic antitumor interactions of interleukin-2, α-interferon, and tumor-infiltrating lymphocytes. J. Natl. Cancer Inst., 80: 1393-1397, 1988.
11. Lienard, D., Ewalenko, P , Delmotte, J-J., Renard, N., and Lejeune, F J. High-dose recombinant tumor necrosis factor α in combination with interferon γ and Melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J Clin. Oncol., 10: 52-60 1992
12. Creasey, A. A , Reynolds, M T , and Laird, W Cures and partial regression of murine and human tumors by recombinant human tumor necrosis factor. Cancer Res , 46: 5687-5690, 1986
13. Haveli, E. A., Fiers, W., and North, R. J. The antitumor function of tumor necrosis factor (TNF) 1 Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity J Exp. Med , 167: 1067-1085, 1988
14. Moritz, T., Niederle, N., Baumann, J., May, D., Kurschel, E., Osieka, R , Kempeni, J., Schlick, E., and Schmidt, C Phase I study of recombinant human tumor necrosis factor α in advanced malignant disease. Cancer Immunol. Immunother, 29: 144-150, 1989.
15. Abbruzzese, J., Levin, B , Ajam, J. A., Faintuch, J. S , Saks, S., Patt, Y Z., Edwards, C., Ende, K , and Gutterman, J. U. Phase I trial of recombinant human γ-interferon and recombinant human tumor necrosis factor in patients with advanced gastrointestinal cancer. Cancer Res , 49: 4057-4061, 1989.
16. Lejeune, F. J. High dose recombinant tumor necrosis factor (rTNFα) administered by isolation perfusion for advanced tumors of the limbs: a model for biochemotherapy of cancer. Eur. J. Cancer, 31A: 1009-1016, 1995.
17. Mavligit, G. M., Zukiwski, A A , Charnsangavej, C, Humberto Carrasco, C., Wallace, S., and Gutterman, J U. Regional biologic therapy hepatic arterial infusion of recombinant human tumor necrosis factor in patients with liver metastases. Cancer (Phila.), 69: 557-561, 1992.
18. van der Schelling, G P , Ijzermans, J. N. M., Kok, T C , Scheringa, M., Marquet, R L., Splinter, T A. W., and Jeekel, J. A phase I study of local treatment of liver metastases with recombinant tumour necrosis factor. Eur. J. Cancer, 28A: 1073-1078, 1992.
19. Buchegger, F., Haskell, C. M., Schreyer, M., Scazziga, B. R., Randin, S., Carrel, S., and Mach, J-P. Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice. J. Exp Med., 158: 413-427, 1983.
20. Delaloye, B , Bischof-Delaloye, A., Buchegger, F., von Fliedner, V., Grob, J-P., Volant, J. C , Pettavel, J., and Mach, J-P. Detection of colorectal carcinoma by emission-computerized tomography after injection of 123-I-labeled Fab or F(ab′)2 fragments from monoclonal anti-carcinoembryonic antigen antibodies. J. Clin Invest, 77 301-311, 1986.
21. Kohler, G., Howe, S. C., and Milstein, C Fusion between immunoglobulin-secreting and nonsecreting myeloma cell lines. Eur. J. Immunol., 6: 292-295, 1976
22. 2 antibody containing thioether-linked Fab′ fragments. J. Immunol., 139: 2367-2375, 1987.
23. Griffiths, A D., Malmqvist, M., Marks, J. D , Bye, J. M., Embleton, M. J., McCafferty, J., Baier, M , Holliger, K. P., Gorick, B. D., Hughes-Jones, N. C., Hoogenboom, H R., and Winter, G. Human anti-self antibodies with high specificity from phage display libraries. EMBO J., 12: 725-734, 1993.
24. Holliger, P., Prospero, T , and Winter, G. "Diabodies" small bivalent and bispecific antibody fragments. Proc. Natl. Acad. Sci USA, 90: 6444-6448, 1993.
25. Martin, K. W., and Halpern, S. E Carcinoembryonic antigen production, secretion and kinetics in BALB/c mice and a nude mouse-human tumor model. Cancer Res., 44: 5475-5481, 1984.
26. Palladino, M. A., Jr., Refaat Shalaby, M., Kramer, S. M., Ferraiolo, B. L , Baughman, R A., Deleo, A. B., Crase, D , Marafino, B., Aggarwal, B. B., Figari, I. S., Liggitt, D. and Patton, J. S. Characterization of the antitumor activities of human tumor necrosis factor-α and the comparison with other cytokines: induction of tumor-specific immunity. J. Immunol., 138: 4023-4032, 1987.
27. LeBerthon, B., Khawli, L. A , Alauddin, M., Miller, G. K , Charak, B. S., Mazumder, A , and Epstein, A. L Enhanced tumor uptake of macromolecules induced by a novel vasoactive mterleukin 2 immunoconjugate. Cancer Res., 51: 2694-2698, 1991.
28. Khawli, L. A., Miller, G. K., and Epstein, A. L. Effect of seven new vasoactive immunoconjugates on the enhancement of monoclonal antibody uptake in tumors. Cancer (Phila.), 73: 824-831, 1994
29. Rosenblum, M G., Cheung, L., Murray, J. L., and Bartholomew, R. Antibody-mediated delivery of tumor necrosis factor (TNF-α): improvement of cytotoxicity and reduction of cellular resistance Cancer Commun , 3: 21-27, 1991
30. Yang, J , Moyana, T , and Xiang, J. A genetically engineered single-chain FV/TNF molecule possesses the anti-tumor immunoreactivity of FV as well as the cytotoxic activity of tumor necrosis factor. Mol. Immunol., 32: 873-881, 1995.
31. Hoogenboom, H R., Raus, J. C , and Volckaert, G. Targeting of tumor necrosis factor to tumor cells: secretion by myeloma cells of a genetically engineered antibody-tumor necrosis factor hybrid molecule. Biochim. Biophys Acta, 1096: 345-354, 1991.
32. Asher, A. L., Mule, J J , Kasid, A , Restifo, N. P., Salo, J. C., Reichert, C. M., Jaffe, G., Fendly, B , Kriegler, M., and Rosenberg, S. A. Murine tumor cells transduced with the gene for tumor necrosis factor-α Evidence for paracrine immune effects of tumor necrosis factor against tumors. J. Immunol , 146: 3227-3234, 1991.
33. Mullen, C. A , Coale, M M., Levy, A T., Stetler-Stevenson, W G., Liotta, L. A., Brandt, S., and Blaese, R. M. Fibrosarcoma cells transduced with the IL-6 gene exhibited reduced tumorigenicity, increased immunogenicity, and decreased metastatic potential Cancer Res , 52: 6020-6024, 1992.
34. Watanabe, N , Niitsu, Y., Umeno, H , Kuriyama, H., Neda, H., Yamauchi, N., Maeda, M., and Urushizaki, I. Toxic effect of tumor necrosis factor on tumor vasculature in mice Cancer Res., 48: 2179-2183, 1988.
35. Gridley, D. S., Hammond, S. N , and Liwnicz, B. H Tumor necrosis factor-α augments radiation effects against human colon tumor xenografts. Anticancer Res., 14: 1107-1112, 1994
36. Leonard, M. P , Jeffs, R D., Gearhart, J. P., and Coffey, D. S. Recombinant human tumor necrosis factor enhances radiosensitivity and improves animal survival in murine neuroblastoma. J. Urol , 148: 743-746, 1992.
37. Gridley, D. S., Glisson, W, C., and Uhm, J. R Interaction of tumour necrosis factor-α and radiation against human colon tumour cells. Ther. Immunol., 1: 25-31, 1994
38. Chen, M., Quintans, J., Fuks, Z., Thompson, C., Kufe, D. W., and Weichselbaum, R. R. Suppression of Bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor α, and ceramide. Cancer Res., 55: 991-994, 1995.
39. Folli, S., Pèlegrin, A , Chalandon, Y., Yo, X., Buchegger, F , Lejeune, F., and Mach, J-P. Tumor necrosis factor can enhance radio-antibody uptake in human colon carcinoma xenografts by selective increase of vascular permeability. Int. J. Cancer, 55: 829-836, 1993.
40. 2 conjugate. Eur. J Cancer, 29A: 1177-1183, 1993
41. Rowlinson Busza, G., Maraveyas, A., and Epenetos, A. A. Effect of tumour necrosis factor on the uptake of specific and control monoclonal antibodies in a human tumour xenograft model. Br J. Cancer. 71: 660-665, 1995.
42. Barr, I. G., Miescher, S., von Fliedner, V., Buchegger, F., Barras, C., Lanzavecchia, A., Mach, J-P., and Carrel, S. In vivo localization of a bispecific antibody which targets human T lymphocytes to lyse human colon cancer cells Int. J Cancer, 43: 501-507, 1989
43. 2 fragments of monoclonal antiferritin in nude mouse model. J. Nucl. Med, 34 2152-2159, 1993.
44. Pèlegrin, A., Folli, S., Buchegger, F., Mach, J. P., Wagnières, G , and van den Bergh, H. Antibody-fluorescein conjugates for photoimmunodiagnosis of human colon carcinoma in nude mice. Cancer (Phila). 67: 2529-2537, 1991
45. Kurth, M , Pèlegrin, A , Rose, K., Offord, R. E., Pochon, S , Mach, J-P., and Buchegger, F. Site-specific conjugation of a radioiodinated phenethylamine derivative to a monoclonal antibody results in increased radioactivity localization in tumor. J Med Chem., 36: 1255-1261, 1993.
46. Jain, R. K. Determinants of tumor blood flow: a review. Cancer Res., 48: 2641-2658, 1988.
47. Tartaglia, L A , and Goeddel, D. V. Two TNF receptors (Review). Immunol. Today, 13: 151-153, 1992
48. Tracey, K. J , Fong, Y , Hesse, D. G., Manogue, K. R , Lee, A. T , Kuo, G. C., Lowry, S. F., and Cerami, A. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature (Lond.), 330: 662-664, 1987
49. Ashkenazi, A , Marsters, S. A , Capon, D. J., Chamow, S. M., Figari, I S , Pennica, D , Goeddel, D. V., Palladino, M. A., and Smith, D. H Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin. Proc. Natl. Acad. Sci. USA, 88: 10535-10539, 1991.
50. Rosenblum, M. G., Cheung, L., Mujoo, K., and Murray, J. L An antimelanoma immunotoxin containing recombinant human tumor necrosis factor tissue disposition, pharmacokinetic, and therapeutic studies in xenograft models. Cancer Immunol. Immunother., 40: 322-328, 1995.